FDA Targets Insulin for Increased Competition to Lower Prices

Jan 4, 2018

Connecture data was cited in this latest Bloomberg news article, which discusses the price increase in certain diabetes medicine. As a result, the FDA announced that it will expedite company applications for generic insulin. Read the full article here.